Lazard Asset Management’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,669
| Closed | -$110K | – | 2473 |
|
|
2024
Q4 | $110K | Sell |
2,669
-11,516
| -81% | -$475K | ﹤0.01% | 1780 |
|
|
2024
Q3 | $947K | Sell |
14,185
-36,937
| -72% | -$2.47M | ﹤0.01% | 1099 |
|
|
2024
Q2 | $6.07M | Buy |
51,122
+40,951
| +403% | +$4.86M | 0.01% | 634 |
|
|
2024
Q1 | $1.08M | Buy |
10,171
+4,563
| +81% | +$485K | ﹤0.01% | 912 |
|
|
2023
Q4 | $556K | Sell |
5,608
-2,409
| -30% | -$239K | ﹤0.01% | 1083 |
|
|
2023
Q3 | $827K | Buy |
8,017
+1,078
| +16% | +$111K | ﹤0.01% | 1019 |
|
|
2023
Q2 | $842K | Sell |
6,939
-9,654
| -58% | -$1.17M | ﹤0.01% | 1023 |
|
|
2023
Q1 | $2.55M | Buy |
16,593
+510
| +3% | +$78.3K | ﹤0.01% | 871 |
|
|
2022
Q4 | $2.89M | Sell |
16,083
-43,824
| -73% | -$7.87M | ﹤0.01% | 834 |
|
|
2022
Q3 | $7.08M | Buy |
59,907
+19,799
| +49% | +$2.34M | 0.01% | 638 |
|
|
2022
Q2 | $5.73M | Buy |
40,108
+23,274
| +138% | +$3.32M | 0.01% | 709 |
|
|
2022
Q1 | $2.9M | Sell |
16,834
-29,655
| -64% | -$5.11M | ﹤0.01% | 838 |
|
|
2021
Q4 | $11.8M | Sell |
46,489
-43,500
| -48% | -$11M | 0.01% | 593 |
|
|
2021
Q3 | $34.6M | Buy |
89,989
+506
| +0.6% | +$195K | 0.04% | 357 |
|
|
2021
Q2 | $21M | Buy |
89,483
+69,859
| +356% | +$16.4M | 0.02% | 456 |
|
|
2021
Q1 | $2.57M | Buy |
19,624
+16,995
| +646% | +$2.22M | ﹤0.01% | 757 |
|
|
2020
Q4 | $274K | Buy |
+2,629
| New | +$274K | ﹤0.01% | 1058 |
|